Sign inGet started

Peterson Katharine

Insider CIK 2022214 · ACRV Chief Accounting Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACRV Acrivon Therapeutics, Inc. S Sale2026-08-182026-08-20101$2.01 $20318,033SEC↗
ACRV Acrivon Therapeutics, Inc. S Sale2026-08-182026-08-20101$2.01 $20318,033SEC↗
ACRV Acrivon Therapeutics, Inc. A Award2026-05-182026-05-2014,227— $018,134SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2026-05-142026-05-1899$1.92 $1903,907SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2026-03-012026-03-0331,900— $031,900SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2026-02-142026-02-18116$1.63 $1894,006SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2025-11-142025-11-1899$2.24 $2224,122SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2025-08-142025-08-1899$1.39 $1384,221SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2025-05-142025-05-1699$1.14 $1134,320SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2025-03-012025-03-0431,900— $031,900SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2025-02-142025-02-19116$5.42 $6294,419SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2024-11-142024-11-1899$7.92 $7844,535SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2024-08-142024-08-1699$7.02 $6954,634SEC↗
ACRV Acrivon Therapeutics, Inc. F Tax w/h2024-05-142024-05-1699$8.36 $8284,733SEC↗